ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2107

Assessing Subclinical Synovitis in Rheumatoid Arthritis: Arthrosonographic Findings in Patients with Good Response to Therapy

Matthias Witt1, Felix Mueller2, Axel Nigg2, Christiane Reindl3, Hendrik Schulze-Koops2 and Mathias Grunke2, 1Division of Rheumatology and Clinical Immunology, Medizinische Klinik und Poliklinik IV, University of Munich, Munich, Germany, 2Division of Rheumatology, Division of Rheumatology and Clinical Immunology, Medizinische Klinik und Poliklinik IV, University of Munich, Munich, Germany, 3Division for Rheumatology, Division of Rheumatology and Clinical Immunology, Medizinische Klinik und Poliklinik IV, University of Munich, Munich, Germany

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Doppler ultrasound, remission, Rheumatoid arthritis (RA), synovitis and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects III: Infections/Risk Factors for Incident Rheumatoid Arthritis/Metrology/Classification/Biomarkers/Predictors of Rheumatolid Arthritis Activity & Severity

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Treat-to-target is a key principle in rheumatoid arthritis. Composite scores such as the DAS-28 help to monitor disease activity and response to therapy. However, in patients without clinical activity, ultrasound examination may reveal subclinical synovitis. While some findings have prognostic relevance, little is known about the relevance of borderline (grade 1) ultrasound findings in asymptomatic joints of patients with good response to therapy. This study was undertaken to give a sonographic analysis of subclinical synovitis in this subset of RA patients.

Methods:

Patients with newly diagnosed RA were included. At baseline, patients were assessed by clinical examination and ultrasound. Ultrasound was performed with grey scale (GSUS) and power Doppler (PDUS) in the metacarpophalangeal, proximal interphalangeal, metatarsophalangeal and wrist joints, using the dorsal approach in each joint. Synovitic findings in GSUS and PDUS were graded semiquantitatively from 0 to 3 as specified before. After the initial assessment, patients were treated with anti-rheumatic drugs according to national guidelines and were seen on a regular outpatient basis. Clinical and sonographic reevaluation together with assessment of EULAR responses was performed at month 6.  

Results:

Sofar, 40 patients were included into this ongoing study. Patients’ characteristics are consistent with a typical RA cohort. By month 6, good, moderate and no EULAR responses were reached by 65.7%, 25.7% and 8.6% of the patients, respectively. In the group with good EULAR response, 7.2% of the joints had clinical synovitis, while 92.8% of the joints were asymptomatic. In the asymptomatic group, ultrasound detected subclinical synovitis in 11.1% in GSUS and in 3.8% in PDUS with significant differences for both modalities in comparison to the clinically apparent group. The sonographic findings in the subclinical group could be classified as grade 1, grade 2 and grade 3 in 78.9%, 19.7% and 1.3% in GSUS, and in 76.9%, 23.0% and 0% in PDUS. Grade 1 GSUS and PDUS findings were found significantly more often in the subclinical group, while non-grade 1, i.e. grade 2 and grade 3 GSUS and PDUS findings were significantly more prevalent in the clinically apparent group.

Conclusion:

More than 90% of the joints were asymptomatic in the group with good response. Ultrasound of these joints revealed subclinical synovitis in 11.1% in GSUS and in 3.8% in PDUS. Concerning the pattern of ultrasound findings, grade 1 findings were most prevalent in both modalities and were found significantly more often than in the clinically apparent group. Of note, grade 1 GSUS findings are also found in healthy individuals and hence, the clinical relevance seems to be questionable. While persistent PDUS activity in general has been linked to clinical relapses in asymptomatic patients, the specific relevance of grade 1 PDUS findings needs to be further clarified. Taken together, these data indicate that the relevance of subclinical synovitis may be overestimated in asymptomatic joints of patients with a good clinical treatment response. In this situation ultrasound seems to add little to the clinical overall impression. Further analysis is underway to clarify the role of grade 1 PDUS findings.


Disclosure:

M. Witt,
None;

F. Mueller,
None;

A. Nigg,
None;

C. Reindl,
None;

H. Schulze-Koops,
None;

M. Grunke,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessing-subclinical-synovitis-in-rheumatoid-arthritis-arthrosonographic-findings-in-patients-with-good-response-to-therapy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology